The American Diabetes Association's Standards of Medical Care in Diabetes does not list colorectal cancer risk as a consideration when prescribing GLP-1 receptor agonists
However, it's important to note that this formulation may also increase the risk of certain side effects, such as nausea, vomiting, and diarrhea
So that initial version that you were talking about, is that the same version that you have today with the transdermal oral supplement
This peptide is a synthetic analogue of amylin, a naturally occurring protein released by the pancreas
Hydrophobic BAs, such as chenodeoxycholic acid (CDCA) and deoxycholic acid (DCA), have been shown to impair epithelial barrier function by disrupting the expression and structural integrity of tight junction proteins, including Occludin, ZO-1, and Claudins 151
Are you gaining weight